CHURCHILL MANAGEMENT Corp Sells 624 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

CHURCHILL MANAGEMENT Corp reduced its holdings in UnitedHealth Group Incorporated (NYSE:UNHGet Rating) by 1.9% in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 32,908 shares of the healthcare conglomerate’s stock after selling 624 shares during the quarter. UnitedHealth Group comprises 0.4% of CHURCHILL MANAGEMENT Corp’s holdings, making the stock its 23rd largest holding. CHURCHILL MANAGEMENT Corp’s holdings in UnitedHealth Group were worth $16,903,000 as of its most recent SEC filing.

A number of other hedge funds have also added to or reduced their stakes in the business. Signature Estate & Investment Advisors LLC raised its stake in shares of UnitedHealth Group by 1.2% during the 1st quarter. Signature Estate & Investment Advisors LLC now owns 1,606 shares of the healthcare conglomerate’s stock valued at $820,000 after purchasing an additional 19 shares during the period. Steph & Co. raised its stake in shares of UnitedHealth Group by 1.6% during the 1st quarter. Steph & Co. now owns 1,290 shares of the healthcare conglomerate’s stock valued at $658,000 after purchasing an additional 20 shares during the period. First City Capital Management Inc. raised its stake in shares of UnitedHealth Group by 1.5% during the 1st quarter. First City Capital Management Inc. now owns 1,350 shares of the healthcare conglomerate’s stock valued at $688,000 after purchasing an additional 20 shares during the period. Griffin Asset Management Inc. raised its stake in shares of UnitedHealth Group by 0.3% during the 1st quarter. Griffin Asset Management Inc. now owns 6,695 shares of the healthcare conglomerate’s stock valued at $3,414,000 after purchasing an additional 21 shares during the period. Finally, Physicians Financial Services Inc. increased its stake in UnitedHealth Group by 5.2% in the 1st quarter. Physicians Financial Services Inc. now owns 424 shares of the healthcare conglomerate’s stock worth $216,000 after acquiring an additional 21 shares during the last quarter. 87.25% of the stock is currently owned by institutional investors.

UnitedHealth Group Trading Down 0.4 %

UNH opened at $521.02 on Monday. The business has a 50 day simple moving average of $529.29 and a two-hundred day simple moving average of $511.81. The firm has a market capitalization of $487.35 billion, a price-to-earnings ratio of 27.21, a PEG ratio of 1.63 and a beta of 0.76. The company has a debt-to-equity ratio of 0.60, a current ratio of 0.77 and a quick ratio of 0.77. UnitedHealth Group Incorporated has a one year low of $383.12 and a one year high of $553.29.

UnitedHealth Group (NYSE:UNHGet Rating) last released its quarterly earnings results on Friday, July 15th. The healthcare conglomerate reported $5.57 EPS for the quarter, beating analysts’ consensus estimates of $5.24 by $0.33. The business had revenue of $80.33 billion during the quarter, compared to analyst estimates of $79.68 billion. UnitedHealth Group had a return on equity of 25.45% and a net margin of 5.95%. UnitedHealth Group’s quarterly revenue was up 12.6% compared to the same quarter last year. During the same quarter in the prior year, the company posted $4.70 EPS. Analysts predict that UnitedHealth Group Incorporated will post 21.85 EPS for the current year.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, September 20th. Stockholders of record on Monday, September 12th will be given a $1.65 dividend. This represents a $6.60 annualized dividend and a dividend yield of 1.27%. The ex-dividend date of this dividend is Friday, September 9th. UnitedHealth Group’s dividend payout ratio is currently 34.46%.

Insider Transactions at UnitedHealth Group

In other news, EVP Erin Mcsweeney sold 1,273 shares of the stock in a transaction that occurred on Thursday, June 23rd. The stock was sold at an average price of $499.00, for a total value of $635,227.00. Following the completion of the transaction, the executive vice president now owns 8,104 shares of the company’s stock, valued at approximately $4,043,896. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In related news, EVP Erin Mcsweeney sold 1,273 shares of the firm’s stock in a transaction that occurred on Thursday, June 23rd. The stock was sold at an average price of $499.00, for a total transaction of $635,227.00. Following the completion of the transaction, the executive vice president now owns 8,104 shares of the company’s stock, valued at approximately $4,043,896. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, CEO Andrew Witty sold 11,376 shares of the firm’s stock in a transaction that occurred on Monday, July 18th. The shares were sold at an average price of $527.90, for a total value of $6,005,390.40. Following the transaction, the chief executive officer now directly owns 76,559 shares of the company’s stock, valued at approximately $40,415,496.10. The disclosure for this sale can be found here. In the last quarter, insiders sold 140,324 shares of company stock valued at $75,086,185. Corporate insiders own 0.40% of the company’s stock.

Analysts Set New Price Targets

UNH has been the topic of a number of research analyst reports. SVB Leerink upped their target price on UnitedHealth Group from $600.00 to $625.00 and gave the stock an “outperform” rating in a research note on Monday, July 18th. Loop Capital initiated coverage on UnitedHealth Group in a research note on Thursday, June 16th. They issued a “buy” rating and a $575.00 target price on the stock. Oppenheimer upped their target price on UnitedHealth Group from $600.00 to $610.00 and gave the stock an “outperform” rating in a research note on Monday, July 18th. BMO Capital Markets upped their price objective on UnitedHealth Group from $600.00 to $610.00 in a report on Wednesday, July 20th. Finally, Wells Fargo & Company cut their price objective on UnitedHealth Group from $613.00 to $612.00 and set an “overweight” rating for the company in a report on Wednesday, May 25th. Three analysts have rated the stock with a hold rating, fifteen have given a buy rating and two have given a strong buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $585.65.

UnitedHealth Group Profile

(Get Rating)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.

Featured Articles

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHGet Rating).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.